Search Results - "FERBER, F"

Refine Results
  1. 1

    Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study by Audran, R., Chtioui, H., Thierry, A. C., Mayor, C. E., Vallotton, L., Dao, K., Rothuizen, L. E., Maghraoui, A., Pennella, E. J., Brunner-Ferber, F., Buclin, T., Spertini, F.

    Published in Scientific reports (04-06-2024)
    “…The initial Phase-I single centre, single dose, randomized, double-blind, cross-over study was planned to assess the pharmacokinetic and pharmacodynamic…”
    Get full text
    Journal Article
  2. 2

    Evaluating the Importance of Non-Unique Behavioural Parameter Sets on Surface Water Quality Variables under Climate Change Conditions in a Mesoscale Agricultural Watershed by Mehdi, B., Schulz, K., Ludwig, R., Ferber, F., Lehner, B.

    Published in Water resources management (01-01-2018)
    “…The parameter uncertainty in the eco-hydrological model Soil and Water Assessment Tool (SWAT) was estimated using non-unique parameter sets for the Altmühl…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats by Gardiner, S M., Kemp, P A., Brunner‐Ferber, F., Bennett, T.

    Published in British journal of pharmacology (01-12-1997)
    “…1 The effects of combined inhibition of neutral endopeptidase 24.11 and angiotensin‐converting enzyme, with the dual metallopeptidase inhibitor, MDL 100,240 (3…”
    Get full text
    Journal Article
  7. 7

    Bioavailability of repeated oral administration of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase in healthy volunteers by ROUSSO, P, BUCLIN, T, NUSSBERGER, J, BRUNNER-FERBER, F, BRUNNER, H. R, BIOLLAZ, J

    Published in European journal of clinical pharmacology (01-01-2000)
    “…MDL 100,240 (pyrido[2,1-a] [2]benzazepine-4-carboxylic acid,7-[[2-(acetylthio)-1-oxo-3-phenylpropyl]amino]-1,2,3,4,6,7,8, 12b-octahydro-6-oxo,…”
    Get full text
    Journal Article
  8. 8

    Comparative effects of the dual metallopeptidase inhibitor, MDL 100,240 and of enalaprilat on regional and on cardiac haemodynamics in conscious, hypertensive, transgenic ((mRen‐2)27) rats by Gardiner, S M., Kemp, P A., Brunner‐Ferber, F., Bennett, T.

    Published in British journal of pharmacology (01-12-1997)
    “…1 Heterozygous, male, hypertensive, transgenic ((mRen‐2)27) rats (350–450 g) were instrumented for the measurement of regional or cardiac haemodynamics (n =…”
    Get full text
    Journal Article
  9. 9

    Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humans by Pentikainen, P J, Saraheimo, M, Schwartz, J I, Amin, R D, Schwartz, M S, Brunner-Ferber, F, Rogers, J D

    Published in Journal of clinical pharmacology (01-02-1992)
    “…Twelve healthy male volunteers received single market-image 40-mg oral doses of lovastatin and simvastatin (both lactone prodrugs), or pravastatin (a…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Urinary Recovery of N-Formimidoyl Thienamycin (MK0787) as Affected by Coadministration of N-Formimidoyl Thienamycin Dehydropeptidase Inhibitors by Norrby, S R, Alestig, K, Björnegård, B, Burman, L A, Ferber, F, Huber, J L, Jones, K H, Kahan, F M, Kahan, J S, Kropp, H, Meisinger, M A, Sundelof, J G

    Published in Antimicrobial Agents and Chemotherapy (01-02-1983)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  12. 12

    A single dose of the topical carbonic anhydrase inhibitor MK-927 decreases IOP in patients by Pfeiffer, N, Hennekes, R, Lippa, E A, Grehn, F, Garus, H, Brunner-Ferber, F L

    Published in British journal of ophthalmology (01-07-1990)
    “…MK-927 is a novel topical carbonic anhydrase inhibitor (CAI). We present the first single-dose clinical trial of MK-927 in 24 patients with bilateral primary…”
    Get full text
    Journal Article
  13. 13

    Disposition of radiolabeled imipenem and cilastatin in normal human volunteers by NORRBY, S. R, ROGERS, J. D, FERBER, F, JONES, K. H, ZACCHEI, A. G, WEIDNER, L. L, DEMETRIADES, L, GRAVALLESE, D. A, HSIEH, J. Y.-K

    Published in Antimicrobial Agents and Chemotherapy (01-11-1984)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  14. 14

    Site of the action of a synthetic atrial natriuretic peptide evaluated in humans by Biollaz, Jérôme, Bidiville, Jacques, Diézi, Jacques, Waeber, Bernard, Nussberger, Jürg, Brunner–Ferber, Françoise, Gomez, Hector J., Brunner, Hans R.

    Published in Kidney international (01-10-1987)
    “…Site of the action of a synthetic atrial natriuretic peptide evaluated in humans. The renal site of the natriuretic effect of human, atrial natriuretic peptide…”
    Get full text
    Journal Article
  15. 15

    Three new long-acting converting-enzyme inhibitors: relationship between plasma converting-enzyme activity and response to angiotensin I by Biollaz, J, Burnier, M, Turini, G A, Brunner, D B, Porchet, M, Gomez, H J, Jones, K H, Ferber, F, Abrams, W B, Gavras, H, Brunner, H R

    Published in Clinical pharmacology and therapeutics (01-05-1981)
    “…Three new angiotensin converting-enzyme inhibitors were given orally to 20 men in single doses ranging from 1.25 to 40 mg. Two of them induced comparable…”
    Get more information
    Journal Article
  16. 16

    Whole-blood pharmacokinetics and metabolic effects of the topical carbonic anhydrase inhibitor dorzolamide by Biollaz, J, Munafo, A, Buclin, T, Gervasoni, J P, Magnin, J L, Jaquet, F, Brunner-Ferber, F

    “…Following a single-dose, open-label, pilot pharmacokinetic study in six subjects, the systemic pharmacokinetics and metabolic effects of dorzolamide after…”
    Get full text
    Journal Article
  17. 17

    Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects by Brunner, DB, Desponds, G, Biollaz, J, Keller, I, Ferber, F, Gavras, H, Brunner, HR, Schelling, JL

    Published in British journal of clinical pharmacology (01-05-1981)
    “…1 MK 421 and its lysine analogue are two new inhibitors of angiotensin converting enzyme. Ten mg of both compounds were each given p.o. to 12 normotensive…”
    Get full text
    Journal Article
  18. 18

    Assessment of bronchial effects following topical administration of butylamino‐phenoxy‐propanol‐acetate, an oculoselective beta‐ adrenoceptor blocker in asthmatic subjects by Bauer, KG, Brunner‐Ferber, F, Distlerath, LM, Lippa, EA, Binkowitz, B, Till, P, Kaik, GA

    Published in British journal of clinical pharmacology (01-08-1992)
    “…1. Butylamino‐phenoxy‐propanol‐acetate (BPPA) is a new topical oculoselective beta‐adrenoceptor blocker for the reduction of intraocular pressure (IOP) in man…”
    Get full text
    Journal Article Conference Proceeding
  19. 19

    Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans by Norrby, S R, Alestig, K, Ferber, F, Huber, J L, Jones, K H, Kahan, F M, Meisinger, M A, Rogers, J D

    Published in Antimicrobial Agents and Chemotherapy (01-02-1983)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  20. 20

    Dose-dependent effect of atrial natriuretic peptide on blood pressure, heart rate, and skin blood flow of normal volunteers by Bussien, J P, Biollaz, J, Waeber, B, Nussberger, J, Turini, G A, Brunner, H R, Brunner-Ferber, F, Gomez, H J, Otterbein, E S

    Published in Journal of cardiovascular pharmacology (01-01-1986)
    “…Synthetic atrial natriuretic peptide, containing 26 amino acids in the rat sequence, L-364, 343 (Ileu-ANP), was infused intravenously at increasing rates (1-40…”
    Get more information
    Journal Article